| Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids (NCT04928157) | University of California, San Diego | 2021-08-10 |
| Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China (NCT04954131) | Zhejiang Clover Biopharmaceuticals, Inc. | 2021-08-10 |
| EXHIT ENTRE Comparative Effectiveness Trial (NCT04345718) | Gavin Bart | 2021-08-09 |
| AuriNovo for Auricular Reconstruction (NCT04399239) | 3DBio Therapeutics | 2021-08-09 |
| Clinical Trial Enzyme Application Targeting Venous Leg Ulcers (NCT04956900) | SolasCure Limited | 2021-08-09 |
| A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors (NCT04577963) | Hutchmed | 2021-08-09 |
| Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma (NCT05436223) | Hrain Biotechnology Co., Ltd. | 2021-08-09 |
| Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (NCT04971785) | Gilead Sciences | 2021-08-09 |
| Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis (NCT04749667) | Haukeland University Hospital | 2021-08-09 |
| A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer (NCT05004116) | Memorial Sloan Kettering Cancer Center | 2021-08-09 |
| The KHENEREXT Study (NCT04604548) | Khondrion BV | 2021-08-09 |
| Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04815720) | Vaccinex Inc. | 2021-08-09 |
| CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease (NCT04526288) | Fred Hutchinson Cancer Center | 2021-08-09 |
| Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer (NCT04881929) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-08-09 |
| A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome; (NCT04939363) | Bnai Zion Medical Center | 2021-08-08 |
| A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs. (NCT05026320) | Bayer | 2021-08-08 |
| Biology Guided Therapy for Breast Cancer for ER Positive (NCT04965688) | Inova Health Care Services | 2021-08-08 |
| Analgesia After Laparoscopic Cholecystectomy (NCT04715165) | Assiut University | 2021-08-07 |
| Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (NCT04643379) | Washington University School of Medicine | 2021-08-07 |
| Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis (NCT05002686) | Ruijin Hospital | 2021-08-07 |
| Exercise Intervention for Bone Tumor Patients (NCT04963517) | Universität Duisburg-Essen | 2021-08-07 |
| Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT04857359) | Addex Pharma S.A. | 2021-08-06 |
| A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) (NCT04933227) | Hoffmann-La Roche | 2021-08-06 |
| BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study) (NCT04839471) | National Health Research Institutes, Taiwan | 2021-08-06 |
| ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors (NCT04891198) | 3D Medicines (Sichuan) Co., Ltd. | 2021-08-06 |
| Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage (NCT04857632) | Capital Medical University | 2021-08-06 |
| A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 (NCT04999111) | Janssen Vaccines & Prevention B.V. | 2021-08-06 |
| Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 (NCT04883528) | Duke University | 2021-08-06 |
| A Controlled Study of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD) in Adults (NCT04839562) | Massachusetts General Hospital | 2021-08-06 |
| COVID-19 Methylene Blue Antiviral Treatment (NCT05004805) | Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences | 2021-08-06 |
| A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia (NCT04899310) | ModernaTX, Inc. | 2021-08-06 |
| Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy (NCT04497038) | University of Michigan Rogel Cancer Center | 2021-08-06 |
| Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 (NCT04787042) | Simcha IL-18, Inc. | 2021-08-06 |
| VE303 for Treatment of Hepatic Encephalopathy (HE) (NCT04899115) | Patricia Bloom | 2021-08-06 |
| Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05162872) | Sun Yat-sen University | 2021-08-05 |
| Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS (NCT04987671) | Amylyx Pharmaceuticals Inc. | 2021-08-05 |
| OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC (NCT04713514) | ARCAGY/ GINECO GROUP | 2021-08-05 |
| Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer (NCT04947254) | M.D. Anderson Cancer Center | 2021-08-05 |
| Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (NCT04733118) | MedSIR | 2021-08-05 |
| Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma (NCT04936841) | University of Wisconsin, Madison | 2021-08-05 |
| NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies (NCT04955730) | H. Lee Moffitt Cancer Center and Research Institute | 2021-08-05 |
| Exploring the Effect of Lactate Administration After Ischemic Stroke on Brain Metabolism (NCT04858139) | Centre Hospitalier Universitaire Vaudois | 2021-08-05 |
| Weight Regain Treatment Post-Bariatric Surgery (NCT04662801) | Yale University | 2021-08-05 |
| CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma (NCT05059912) | The First Affiliated Hospital of Soochow University | 2021-08-05 |
| Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity (NCT05239832) | Livzon Pharmaceutical Group Inc. | 2021-08-05 |
| A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer (NCT04997018) | Memorial Sloan Kettering Cancer Center | 2021-08-04 |
| Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery (NCT04564833) | Renibus Therapeutics, Inc. | 2021-08-04 |
| Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC (NCT04497584) | University of Texas Southwestern Medical Center | 2021-08-04 |
| Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity (NCT04298203) | University of Minnesota | 2021-08-04 |
| Erenumab For Treatment of Hemicrania Continua (NCT04303845) | Mayo Clinic | 2021-08-04 |
| Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer (NCT05218889) | Chinese PLA General Hospital | 2021-08-04 |
| A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction (NCT04969666) | Initiator Pharma | 2021-08-04 |
| A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) (NCT04944992) | Merck Sharp & Dohme LLC | 2021-08-04 |
| Axitinib + Ipilimumab in Advanced Melanoma (NCT04996823) | H. Lee Moffitt Cancer Center and Research Institute | 2021-08-04 |
| Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer (NCT04791839) | Washington University School of Medicine | 2021-08-04 |
| Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea (NCT05045469) | Chang Gung Memorial Hospital | 2021-08-04 |
| Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (NCT04602377) | ARCAGY/ GINECO GROUP | 2021-08-04 |
| Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma (NCT04626791) | Academic and Community Cancer Research United | 2021-08-03 |
| Combination Immunotherapy in Rare Cancers Under InvesTigation (NCT04969887) | Olivia Newton-John Cancer Research Institute | 2021-08-03 |
| A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1) (NCT04994288) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2021-08-03 |
| Evaluation of the Efficacy and Safety of Curalin as Add-On Therapy in Adults With Type 2 Diabetes Mellitus (NCT05439473) | CuraLife | 2021-08-03 |
| Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients (NCT04605978) | Institut de Recherches Internationales Servier | 2021-08-03 |
| The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study (NCT04032925) | Oxford University Hospitals NHS Trust | 2021-08-03 |
| To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors (NCT06558513) | Evopoint Biosciences Inc. | 2021-08-03 |
| A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) (NCT04998760) | Qi Zhou | 2021-08-03 |
| ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 (NCT04988035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-03 |
| Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV (NCT05006170) | Chulalongkorn University | 2021-08-03 |
| Planned Non-operative Management for Rectal Cancer (NCT05241574) | Maria Sklodowska-Curie National Research Institute of Oncology | 2021-08-03 |
| Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina (NCT04988048) | Ministry of Public Health, Argentina | 2021-08-03 |
| A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease (NCT04992065) | Novo Nordisk A/S | 2021-08-03 |
| Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab (NCT05075122) | Martin-Luther-Universität Halle-Wittenberg | 2021-08-02 |
| A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study (NCT05038618) | Medigen Vaccine Biologics Corp. | 2021-08-02 |
| GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors (NCT04977453) | GI Innovation, Inc. | 2021-08-02 |
| Bisantrene Combination for Resistant AML (NCT04989335) | Sheba Medical Center | 2021-08-02 |
| Transgender Estradiol Affirming Therapy (NCT05010707) | Washington University School of Medicine | 2021-08-02 |
| SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer. (NCT04836520) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-02 |
| Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm (NCT05017194) | Jennifer Keiser | 2021-08-02 |
| AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) (NCT04895215) | Vertero Therapeutics | 2021-08-02 |
| FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer (NCT05018182) | West China Hospital | 2021-08-02 |
| A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma (NCT04936529) | Memorial Sloan Kettering Cancer Center | 2021-08-02 |
| Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes (NCT04982575) | Novo Nordisk A/S | 2021-08-02 |
| Ultrasound Guided Intra-sacroiliac Joint Injection: Methylprednisolone Versus Triamcinolone (NCT05134181) | Mansoura University | 2021-08-01 |
| Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise (NCT04909892) | Sorrento Therapeutics, Inc. | 2021-08-01 |
| Olive Leaf Extracts in the Control of Cardiovascular Risk (NCT05297110) | University of Monastir | 2021-08-01 |
| The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC. (NCT04777084) | Hunan Province Tumor Hospital | 2021-08-01 |
| Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease (NCT05152160) | Shenzhen University General Hospital | 2021-08-01 |
| Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL) (NCT04989621) | Sun Yat-sen University | 2021-08-01 |
| RAPA-201 Therapy of Solid Tumors (NCT05144698) | Rapa Therapeutics LLC | 2021-08-01 |
| A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer (NCT04958473) | Tianjin Medical University Second Hospital | 2021-08-01 |
| To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft (NCT05375188) | National Institute of Cardiovascular Diseases, Pakistan | 2021-08-01 |
| Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3) (NCT04148742) | Dizal Pharmaceuticals | 2021-08-01 |
| Hybrid Robot+FES Stroke Rehabilitation (NCT04550728) | University of Maryland, Baltimore | 2021-08-01 |
| Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer (NCT04963595) | Zhiyong Yu | 2021-08-01 |
| Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC (NCT04988607) | Guangdong Association of Clinical Trials | 2021-08-01 |
| Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT04955886) | Fujian Cancer Hospital | 2021-08-01 |
| Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial (NCT04929067) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-08-01 |
| GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma (NCT05178043) | Suzhou Kintor Pharmaceutical Inc, | 2021-08-01 |
| Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients (NCT04891172) | Dow University of Health Sciences | 2021-08-01 |
| Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL (NCT05050630) | Affiliated Hospital to Academy of Military Medical Sciences | 2021-08-01 |
| Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair (NCT04345666) | Orthopedic Institute, Sioux Falls, SD | 2021-08-01 |